Scanningsklinikken Aarhus ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 10.8% 12.4% 12.5% 14.6%  
Credit score (0-100)  0 23 18 18 14  
Credit rating  N/A BB BB BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  0.0 260 550 514 411  
EBITDA  0.0 46.7 -54.6 -13.5 -10.3  
EBIT  0.0 46.7 -54.6 -13.5 -10.3  
Pre-tax profit (PTP)  0.0 46.3 -61.1 -17.0 -12.7  
Net earnings  0.0 35.8 -61.1 -17.0 -12.7  
Pre-tax profit without non-rec. items  0.0 46.3 -61.1 -17.0 -12.7  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 75.8 14.7 -2.3 -15.1  
Interest-bearing liabilities  0.0 5.0 5.2 6.5 6.8  
Balance sheet total (assets)  0.0 176 77.1 74.1 86.0  

Net Debt  0.0 -153 -56.6 -54.0 -54.2  
 
See the entire balance sheet

Volume 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 260 550 514 411  
Gross profit growth  0.0% 0.0% 111.7% -6.5% -20.1%  
Employees  0 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 176 77 74 86  
Balance sheet change%  0.0% 0.0% -56.1% -3.8% 16.1%  
Added value  0.0 46.7 -54.6 -13.5 -10.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 1.0 -1.0 -2.0 -3.0  

Profitability 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 18.0% -9.9% -2.6% -2.5%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 26.6% -43.2% -17.6% -11.5%  
ROI %  0.0% 57.8% -108.6% -102.3% -153.5%  
ROE %  0.0% 47.2% -135.1% -38.3% -15.9%  

Solidity 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  0.0% 43.1% 19.0% -3.1% -14.9%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% -327.8% 103.6% 400.0% 528.3%  
Gearing %  0.0% 6.6% 35.4% -277.4% -45.4%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 17.3% 126.8% 60.2% 36.9%  

Liquidity 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.0 1.8 1.2 1.0 0.9  
Current Ratio  0.0 1.8 1.2 1.0 0.9  
Cash and cash equivalent  0.0 158.1 61.8 60.5 61.0  

Capital use efficiency 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 75.8 14.7 -2.3 -15.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 47 -55 -14 -10  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 47 -55 -14 -10  
EBIT / employee  0 47 -55 -14 -10  
Net earnings / employee  0 36 -61 -17 -13